Skip to main content
Premium Trial:

Request an Annual Quote

Holmes Trial Delay Sought

Elizabeth Holmes, the founder and former CEO of Theranos, is seeking to push back the start of her trial, scheduled for July, as she is pregnant and expects to give birth then, the Wall Street Journal reports.

Holmes was indicted in 2018 on charges of wire fraud and conspiracy to commit wire fraud. The Mercury News reported last year that another fraud charge had been added stemming from a patient's testing results. Theranos once claimed to be able to run a range of blood tests using a small amount of blood from a finger prick. But a series of articles in the Journal beginning in 2015 called the company's ability to run those tests in to question and regulators uncovered testing issues at the company, which closed in 2018.

Prosecutors have alleged that Holmes and Ramesh 'Sunny' Balwani, the company's former president, committed fraud as they knew Theranos could not perform the tests as claimed. Holmes and Balwani have pleaded not guilty.

According to CNBC, her lawyers are seeking to push the start of her trial back to the end of August 2021. Her trial was previously postponed due to the COVID-19 pandemic.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.